Baric Transcribed Interview (Redacted) — page 124
of 155 pages
← p.123 p.125 → · this page in the original PDF · package
DC.Scheduling@LexitasLegal.com
DR. BARIC: The sequence of the SHC014 chimera. So we
provided that, and we also put the WIV1 sequence up in
PubMed and they analyzed that sequence and agreed that it
was not the cause of the pandemic.
MS. SALAZAR: And that was your decision, solely. No
one encourage you or suggested?
DR. BARIC: Nobody encouraged me or suggested it. In
this case I approached the journal because, again, going
back to the transmissible flu studies, it was not just the
creation of the transmissible flu virus that was considered
sensitive information. It was the details of the
technology which also was dual-use. So it's not
necessarily just the creation of the entity or the pathogen
that's gain-or-function or dual-use. The methodology can
be sensitive, and I felt that it was best that we did not
provide that information. So that's one example.
MS. SALAZAR: Okay.
DR. BARIC: The second example, which is the reason
why I'm reluctant to talk about it here, because I do not
want to be responsible as the one who releases it to the
public. If you all choose to do that then you can accept
the responsibility of that.
Sometimes in science you come across findings that are
potentially concerning. And so in this case, Fang Li had
been doing studies using biochemical approaches to identify
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/baric_ti/124
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| baric_ti:utt:01068 | 2026-04-10 | transcript segment | 123–124 |
| baric_ti:utt:01069 | 2026-04-10 | transcript segment | 124 |
| baric_ti:utt:01070 | 2026-04-10 | transcript segment | 124 |
| baric_ti:utt:01071 | 2026-04-10 | transcript segment | 124 |
| baric_ti:utt:01072 | 2026-04-10 | transcript segment | 124 |
| baric_ti:utt:01073 | 2026-04-10 | transcript segment | 124–126 |